Skip to content

Transcranial Ultrasound Via Sonolucent Cranioplasty

Transcranial Ultrasound Via Sonolucent Cranioplasty

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06097845
Enrollment
50
Registered
2023-10-24
Start date
2023-06-27
Completion date
2028-12-31
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cranioplasty, Sonolucent Cranioplasty, Reconstructive Cranioplasty

Keywords

Transcranial Ultrasound, SOC ultrasound, PMMA implant

Brief summary

Transcranial Ultrasound via Sonolucent Cranioplasty is a prospective, single arm, observational, open label (non-blinded) study to collect real world evidence on the use of transcranial ultrasound via sonolucent cranioplasty.

Detailed description

Standard of care (SOC) imaging techniques routinely used for neurosurgical monitoring, namely computed tomography (CT) and magnetic resonance imaging (MRI), present numerous patient, provider, and institutional burdens associated with transport, invasiveness, contrast administration, radiation exposure, imaging delay, and overall global costs. Ultrasound represents a promising alternative that overcomes many of these disadvantages being noninvasive, low-risk, real-time and portable, but is limited by the acoustic impedance of autologous cranial bone. Recently, material innovations enabling both transparent and sonolucent polymethyl methacrylate (PMMA) - a material commonly used for cranial reconstruction with a longstanding history of safety - have facilitated ultrasound windows within patients already receiving cranioplasty as standard of care. Early results applying transcranioplasty ultrasound (TCUS) through sonolucent cranial plates have been encouraging in regard to agreement with SOC imaging and advanced doppler capabilities. That said, limited published data exists commensurate with the novelty of the technique, therefore investigators herein aim to address this paucity by investigating the feasibility and efficacy of TCUS as compared to standard of care postoperative imaging modalities (i.e. MRI & CT) in a prospective, quality control study.

Interventions

Patients who underwent reconstructive sonolucent cranioplasty will receive standard of care postoperative imaging (i.e. CT, MRI) in addition to ultrasound imaging. Ultrasound imaging will be performed by clinicians using FDA-approved ultrasound devices (GE Venue Go, Fujifilm Sonosite X-Porte, GE Volusion E10 and Clarius HD3 etc.) currently used in routine clinical practice.

Sponsors

Northwell Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Provision of signed and dated informed consent form. 2. Stated willingness to comply with all study procedures and availability for the duration of the study. 3. Patients who are undergoing reconstructive sonolucent cranioplasty as standard of care. 4. Male or female, aged ≥ 18.

Exclusion criteria

1\. Patients who are pregnant

Design outcomes

Primary

MeasureTime frameDescription
Identification of Neuroanatomy accuracy of TCUS12 monthsAccuracy metrics related to identification and measurement of neuroanatomy structures using Trasncranial Ultrasound
Diagnostic accuracy of TCUS12 monthsAccuracy metrics related to detection of postoperative complications using Trasncranial Ultrasound

Countries

United States

Contacts

Primary ContactNetanel Ben-Shalom, MD
nbenshalom@northwell.edu212-434-3900
Backup ContactTamika Wong, MPH
twong4@northwell.edu212-434-4836

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026